Company
Headquarters: Rockville, MD, United States
Employees: 3
CEO: Mr. Alan Gold
$779,219
USD as of July 1, 2023
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
U.S. NeuroSurgical Holdings, Inc., through its subsidiaries, engages in the owning and operating stereotactic radiosurgery centers that utilize gamma knife technology. The gamma knife is a stereotactic radio surgical device used to treat brain tumors and other malformations of the brain without invasive surgery. It owns and operates the Southern California Regional Gamma Knife Center at the San Antonio Regional Hospital in Upland, California. U.S. NeuroSurgical Holdings, Inc. was founded in 1993 and is based in Rockville, Maryland.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
U.S. Neurosurgical Holdings, Inc. has the following listings and related stock indices.
Stock: OTC: USNU wb_incandescent